Physician profile
Anna Moloznik
NPI 1487357034
$1,484.94
in general payments reported to CMS, 2019-2025
16 companies · $565 in 2025
The $565 reported for 2025 was more than what 88% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $356 · 2024: $564 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387 · Education: $98.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.54 |
| Education | $98.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $338.69 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $223.89 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $219.14 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $168.16 | 2024-2025 | Veozah |
| Baxter Healthcare | $78.26 | 2024 | Perclot |
| Pfizer INC. | $68.68 | 2023-2024 | |
| Abbvie INC. | $63.29 | 2023-2024 | |
| Hologic Sales and Service, LLC | $61.57 | 2024-2025 | Aptima, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $60.64 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.34 | 2025 | |
| Sage Therapeutics, LLC | $34.28 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $33.39 | 2023-2024 | Twirla |
| Exact Sciences Corporation | $32.16 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $16.44 | 2025 | |
| Evofem Biosciences, INC. | $15.21 | 2025 | Solosec, Phexx, Phexxi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $12.80 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Moloznik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.